FR2404014A1 - Nouveaux steroides et leur procede de preparation - Google Patents

Nouveaux steroides et leur procede de preparation

Info

Publication number
FR2404014A1
FR2404014A1 FR7817206A FR7817206A FR2404014A1 FR 2404014 A1 FR2404014 A1 FR 2404014A1 FR 7817206 A FR7817206 A FR 7817206A FR 7817206 A FR7817206 A FR 7817206A FR 2404014 A1 FR2404014 A1 FR 2404014A1
Authority
FR
France
Prior art keywords
hydroxy
cholecalciferol
cholesterol
intermediates
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7817206A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2404014A1 publication Critical patent/FR2404014A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7817206A 1977-07-18 1978-06-08 Nouveaux steroides et leur procede de preparation Withdrawn FR2404014A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/816,478 US4183852A (en) 1977-07-18 1977-07-18 Process for preparing 25-hydroxycholesterol

Publications (1)

Publication Number Publication Date
FR2404014A1 true FR2404014A1 (fr) 1979-04-20

Family

ID=25220729

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7817206A Withdrawn FR2404014A1 (fr) 1977-07-18 1978-06-08 Nouveaux steroides et leur procede de preparation

Country Status (7)

Country Link
US (1) US4183852A (enExample)
JP (1) JPS5422359A (enExample)
CA (1) CA1150238A (enExample)
DE (1) DE2830019A1 (enExample)
FR (1) FR2404014A1 (enExample)
GB (1) GB1582678A (enExample)
IT (1) IT1097264B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60270A0 (en) * 1979-06-14 1980-09-16 Diamond Shamrock Corp Preparation of 25-ydroxycholesterol
US4336193A (en) * 1980-08-04 1982-06-22 Wisconsin Alumni Research Foundation Process for preparing vitamin D-lactones
US4351767A (en) * 1981-06-29 1982-09-28 Kaiser Emil T Synthesis of 24,25-dihydroxycholesterol
US4411833A (en) * 1982-05-26 1983-10-25 Wisconsin Alumni Research Foundation Method for preparing 26,26,26,27,27,27-hexafluoro-1α,25-dihydroxycholesterol
CA1312637C (en) * 1987-09-17 1993-01-12 Ronald C. Banko Device for storing a plurality of dishes or the like in a plurality of stacks
JPH036144U (enExample) * 1989-06-08 1991-01-22
JPH07504563A (ja) * 1992-02-28 1995-05-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 副産物としてコレステロールを同時に製造しつつ卵黄を脱コレステロールする方法
AU3068497A (en) * 1996-05-06 1997-11-26 Bionumerik Pharmaceuticals, Inc. Process for preparing 27-hydroxy cholesterol and related derivatives
CA2495882A1 (en) * 2002-08-29 2004-03-11 The Regents Of The University Of California Agents and methods for enhancing bone formation
JP4438308B2 (ja) * 2003-04-07 2010-03-24 三菱化学株式会社 ステロイド化合物の製造方法
US9532994B2 (en) * 2003-08-29 2017-01-03 The Regents Of The University Of California Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
JP2008538803A (ja) * 2005-04-23 2008-11-06 イグゼティック エムアーツェー ゲゼルシャフト ミット ベシュレンクテル ハフツング アキシャルピストン機械
JP2009512422A (ja) * 2005-09-02 2009-03-26 ザ リージェンツ オブ ザ ユニヴァーシティー オブ カリフォルニア 骨形成及び抗脂肪細胞形成オキシステロール類
WO2007098281A2 (en) * 2006-02-27 2007-08-30 Regents Of The University Of California Oxysterol compounds and the hedgehog pathway
US20100048944A1 (en) * 2006-07-19 2010-02-25 Farhad Parhami Interactions of hedgehog and liver x receptor signaling pathways
CA2673513A1 (en) 2006-12-19 2008-07-10 The Regents Of University Of California Inhibition of ppar gamma expression by specific osteogenic oxysterols
WO2008115469A2 (en) * 2007-03-16 2008-09-25 The Regents Of The University Of California Role of hedgehog signaling in atherosclerosis and cardiovascular disease
CA2707663C (en) * 2007-12-03 2017-05-30 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
CN107936076B (zh) 2011-09-08 2021-10-15 萨奇治疗股份有限公司 神经活性类固醇、组合物、及其用途
EP2847206A4 (en) 2012-05-07 2016-01-20 Univ California OXYSTEROL ANALOGUE OXY133 FOR INDUCTION OF OSTEOGENESIS AND HEDGEHOG SIGNALING AND ADIPOGENESIS INHIBITION
ES2699445T3 (es) 2013-03-13 2019-02-11 Sage Therapeutics Inc Esteroides neuroactivos y métodos de utilización de los mismos
AU2014259672A1 (en) 2013-05-02 2015-12-03 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents
US11117924B2 (en) 2015-07-06 2021-09-14 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
KR20240137111A (ko) 2015-07-06 2024-09-19 세이지 테라퓨틱스, 인크. 옥시스테롤 및 그의 사용 방법
HK1255500A1 (zh) * 2015-07-06 2019-08-16 Sage Therapeutics, Inc. 氧固醇及其使用方法
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
LT3481846T (lt) 2016-07-07 2021-08-25 Sage Therapeutics, Inc. 11-pakeistieji 24-hidroksisteroliai, skirti naudoti gydant su nmda susijusias būkles
WO2018064649A1 (en) 2016-09-30 2018-04-05 Sage Therapeutics, Inc. C7 substituted oxysterols and methods as nmda modulators
WO2020225830A1 (en) 2019-05-09 2020-11-12 Fermenta Biotech Limited Novel method for synthesizing 25-oh cholesterol/calcifediol from phytosterol
CN112897512B (zh) * 2021-02-03 2022-11-04 中国科学院物理研究所 碳纳米管分散体和选择性分离碳纳米管的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3257384A (en) * 1963-01-04 1966-06-21 Upjohn Co Derivatives of 25-azacholesterol and 22-oxa-25-azacholesterol
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/73 *

Also Published As

Publication number Publication date
JPS5751840B2 (enExample) 1982-11-04
DE2830019A1 (de) 1979-01-25
IT1097264B (it) 1985-08-31
CA1150238A (en) 1983-07-19
GB1582678A (en) 1981-01-14
IT7824940A0 (it) 1978-06-23
JPS5422359A (en) 1979-02-20
US4183852A (en) 1980-01-15

Similar Documents

Publication Publication Date Title
FR2404014A1 (fr) Nouveaux steroides et leur procede de preparation
Confalone et al. Use of intramolecular [3+ 2] cycloaddition reactions in the synthesis of natural products. A stereospecific synthesis of (.+-.)-biotin from cycloheptene
ATE191467T1 (de) Herstellung von amidoester-verbindungen
DE2757157C3 (de) Verfahren zur Herstellung von 16 a -alkylierten Steroiden
DE1668784B2 (de) Verfahren zur herstellung von aldehyden oder ketonen durch oxydation primaerer oder sekundaerer alkohole
FR2411846A1 (fr) Procede de preparation de nouveaux steroides et produits obtenus par le procede
ATE126222T1 (de) Verfahren zur herstellung von tetrahydrofuran und alpha-butyrolacton.
Lee et al. Synthesis of 1, 3-oxazolidines by copper-catalyzed addition of acetone and ethyl diazoacetate to imines
DE3490427T (de) 1,23-Dihydroxyvitamin-D-Verbindungen
EP0034367B1 (de) Verfahren zur hydrolytischen Spaltung von Steroid-20-Carbamaten
DE1568161C3 (de) Verfahren zur Herstellung von alpha, beta-Dlchlorpropionitrll durch lichtkatalysierte Chlorierung von Acrylnitril
DE102004040702B4 (de) Verfahren zur Herstellung eines Dioxazin-Derivats
DE2409971C3 (de) 5-Cholestenderivate und Verfahren zu ihrer Herstellung
EP0005523B1 (de) D-Homosteroide, Verfahren zu deren Herstellung
EP0036159B1 (de) 4-(2,5-Dihydroxyphen-1-yl)-crotonsäure und deren Derivate sowie Verfahren zur Herstellung dieser Verbindungen
DE2331044A1 (de) Diphenylmethan-derivate und verfahren zu deren herstellung
EP0078766A1 (de) Verfahren zur Herstellung von Aminomethylphosphonsäure
DE960813C (de) Verfahren zur Herstellung von ungesaettigten ª†- und ª€-Laktonen
Bartoli et al. Reactivity of acylsilane phenylhydrazones with phosphorus trichloride
DE953975C (de) Verfahren zur Herstellung von in 4(5)-Stellung ungesaettigten 3-Ketopregnanen
DE1568115C3 (de) Verfahren zur Herstellung von 6-HaIogenmethyl-Delta 4,6-3-on-sterolden
Brown et al. 8-Aza Steroids. IV. 1 8-Aza-19-norprogestogens
DE900935C (de) Verfahren zur Herstellung von 12-Brom-3-acyloxy-5,7,9(11)-pregnatrien-20-on-additionsprodukten
DE4319998A1 (de) Verfahren zur Herstellung von Derivaten des Estra-1,3,5(10),14-tetraen-3,17alpha-diols
CH651054A5 (de) Verfahren zur trennung von gemischen von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.

Legal Events

Date Code Title Description
ST Notification of lapse